Leverage has risen as equity compressed, with the debt-to-equity ratio climbing from about 1.0 to well above 2.0 and total equity turning negative at -$34.6M in 2026Q3 against roughly $771M of total debt, indicating a vulnerable capital structure.
Rayonier Advanced Materials Inc. (RYAM) balance sheet — 14-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Total Current Assets | 509.45M | 568.38M | 600.96M | 575.06M | 689.53M | 776.12M | 633.57M | 554.83M | 716M | 646M | 519M | 327M | 320M | 246.06M | 218.62M |
| Cash & Short-Term Investments | 61.14M | 75.39M | 125.22M | 75.77M | 151.8M | 291.82M | 93.65M | 64.03M | 109M | 96M | 326M | 101M | 66M | 22.53M | 3.65M |
| Cash Only | 61.14M | 75.39M | 125.22M | 75.77M | 151.8M | 253.31M | 93.65M | 64.03M | 109M | 96M | 326M | 101M | 66M | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 38.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 216.14M | 195.03M | 216.61M | 216.91M | 212.72M | 203.01M | 237.87M | 181.66M | 199.84M | 181.3M | 37.63M | 68.89M | 69.26M | 71.1M | 77.48M |
| Days Sales Outstanding | 46.68 | 48.54 | 48.5 | 48.18 | 45.21 | 52.64 | 64.61 | 46.34 | 34.18 | 68.86 | 15.8 | 26.72 | 26.4 | 24.79 | 25.82 |
| Inventory | 180.07M | 237.97M | 208M | 207.47M | 265.33M | 230.69M | 170.65M | 251.18M | 321.38M | 302.09M | 118.37M | 125.41M | 140.21M | 128.71M | 116.99M |
| Days Inventory Outstanding | 53.54 | 64.45 | 51.83 | 48.69 | 60.75 | 63.18 | 48.65 | 66.56 | 65.53 | 134.14 | 62.89 | 61.94 | 69.72 | 65.79 | 59.66 |
| Other Current Assets | 0 | 59.99M | 51.13M | 74.9M | 59.67M | 0 | 72.56M | 57.96M | 108.29M | 0 | 0 | 11.8M | 0 | 22.53M | 3.65M |
| Total Non-Current Assets | 898.04M | 1.19B | 1.53B | 1.61B | 1.66B | 1.67B | 1.9B | 1.93B | 1.96B | 2B | 903M | 961M | 984.7M | 874.21M | 701.98M |
| Property, Plant & Equipment | 772.17M | 1.01B | 1.02B | 1.08B | 1.15B | 1.15B | 1.18B | 1.34B | 1.38B | 1.41B | 801M | 804M | 843.4M | 846.29M | 680.75M |
| Fixed Asset Turnover | 1.62x | 1.45x | 1.60x | 1.53x | 1.49x | 1.23x | 1.14x | 1.07x | 1.55x | 0.68x | 1.08x | 1.17x | 1.14x | 1.24x | 1.61x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 3.93M | 10.4M | 17.41M | 24.42M | 31.43M | 38.44M | 45.45M | 52.46M | 59.87M | 0 | 0 | 0 | 0 | 3M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K | -459.42M | -462.71M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 105.06M | 147.4M | 150.21M | 169.94M | 160.14M | 156.19M | 297.1M | 156.89M | 582M | 589M | 50.75M | 59.58M | 62.75M | 27.92M | 18.23M |
| Total Assets | 1.41B | 1.76B | 2.13B | 2.18B | 2.35B | 2.45B | 2.53B | 2.48B | 2.68B | 2.64B | 1.42B | 1.29B | 1.3B | 1.12B | 920.6M |
| Asset Turnover | 0.93x | 0.83x | 0.77x | 0.75x | 0.73x | 0.58x | 0.53x | 0.58x | 0.80x | 0.36x | 0.61x | 0.73x | 0.73x | 0.93x | 1.19x |
| Asset Growth % | -68.03% | -17.43% | -2.43% | -7.02% | -3.99% | -3.35% | 2% | -7.42% | 1.36% | 85.87% | 10.4% | -1.28% | 16.46% | 21.69% | - |
| Total Current Liabilities | 398.16M | 360.38M | 400.16M | 375.83M | 353.68M | 354.56M | 293M | 286.15M | 370M | 307M | 126M | 132M | 131.4M | 1.03B | 95.72M |
| Accounts Payable | 199.97M | 190.45M | 196.25M | 186.23M | 163.96M | 169.46M | 156.72M | 153.18M | 181.71M | 157.93M | 36.38M | 44.99M | 64.7M | 54.2M | 65.94M |
| Days Payables Outstanding | 50.28 | 51.58 | 48.9 | 43.71 | 37.54 | 46.41 | 44.68 | 40.59 | 37.05 | 70.12 | 19.33 | 22.22 | 32.17 | 27.7 | 33.63 |
| Short-Term Debt | 33.9M | 20.91M | 23.38M | 25.28M | 14.62M | 37.68M | 17.1M | 25.34M | 15.01M | 9.43M | 9.59M | 7.94M | 8.4M | 0 | 0 |
| Deferred Revenue (Current) | 26.85M | 10.36M | 11.13M | 24.06M | 21.64M | 22.52M | 721K | 0 | -192.74M | 53.52M | 34.54M | -44.99M | -64.7M | 0 | 0 |
| Other Current Liabilities | 56.29M | 38.84M | 74.4M | 57.26M | 79.73M | 52.38M | 45.25M | 84.04M | 144.13M | 106.1M | 59.1M | 23.09M | 30.58M | 14.83M | 9.15M |
| Current Ratio | 1.28x | 1.58x | 1.50x | 1.53x | 1.95x | 2.19x | 2.16x | 1.94x | 1.94x | 2.10x | 4.12x | 2.48x | 2.44x | 0.24x | 2.28x |
| Quick Ratio | 0.83x | 0.92x | 0.98x | 0.98x | 1.20x | 1.54x | 1.58x | 1.06x | 1.07x | 1.12x | 3.18x | 1.53x | 1.37x | 0.11x | 1.06x |
| Cash Conversion Cycle | 49.94 | 61.41 | 51.42 | 53.17 | 68.42 | 69.41 | 68.58 | 72.3 | 62.66 | 132.87 | 59.36 | 66.44 | 63.95 | 62.88 | 51.85 |
| Total Non-Current Liabilities | 1.03B | 1.07B | 1.01B | 1.06B | 1.16B | 1.28B | 1.54B | 1.51B | 1.6B | 1.64B | 1.08B | 1.17B | 1.24B | 72.12M | 100.18M |
| Long-Term Debt | 737.44M | 758.11M | 706.44M | 752.17M | 838.51M | 891.03M | 1.07B | 1.06B | 1.17B | 1.23B | 773.69M | 850.12M | 936.42M | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.01M | 3.12M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 31.91M | 12.72M | 13.69M | 15.19M | 17.02M | 20.48M | 24.46M | 24.85M | 28.02M | 32.61M | 0 | 0 | 0 | 49.22M | 47.15M |
| Other Non-Current Liabilities | 288.05M | 299.23M | 284.98M | 293.06M | 309.01M | 364.6M | 450.48M | 406.14M | 397.5M | 376.5M | 309.52M | 314.19M | 298.43M | 22.89M | 53.03M |
| Total Liabilities | 1.43B | 1.43B | 1.41B | 1.44B | 1.52B | 1.63B | 1.83B | 1.8B | 1.97B | 1.95B | 1.21B | 1.3B | 1.37B | 1.1B | 195.9M |
| Total Debt | 771.33M | 779.02M | 729.82M | 777.46M | 853.13M | 928.71M | 1.08B | 1.11B | 1.19B | 1.24B | 783M | 868M | 944.8M | 0 | 0 |
| Net Debt | 710.19M | 703.63M | 604.6M | 701.69M | 701.32M | 675.4M | 990.28M | 1.04B | 1.08B | 1.15B | 457M | 767M | 878.8M | 0 | 0 |
| Debt / Equity | -36.94x | 2.38x | 1.01x | 1.04x | 1.03x | 1.14x | 1.56x | 1.62x | 1.68x | 1.79x | 3.69x | - | - | - | - |
| Debt / EBITDA | -15.49x | 5.36x | 4.13x | 10.41x | 5.31x | 7.26x | 10.04x | 12.33x | 3.45x | 8.08x | 3.46x | 4.15x | 6.36x | - | - |
| Net Debt / EBITDA | -14.26x | 4.85x | 3.42x | 9.39x | 4.36x | 5.28x | 9.17x | 11.62x | 3.14x | 7.45x | 2.02x | 3.67x | 5.91x | - | - |
| Interest Coverage | -2.67x | 0.03x | 0.43x | -0.79x | 0.64x | -0.25x | -0.57x | -1.01x | 3.26x | 9.64x | 4.17x | 4.17x | 2.80x | - | - |
| Total Equity | -20.88M | 327.92M | 724.39M | 746.45M | 829.31M | 814.34M | 695.09M | 682.8M | 707M | 694M | 212M | -17M | -63.8M | 18.3M | 724.7M |
| Equity Growth % | -267.94% | -54.73% | -2.96% | -9.99% | 1.84% | 17.16% | 1.8% | -3.42% | 1.87% | 227.36% | 1347.06% | 73.35% | -448.61% | -97.47% | - |
| Book Value per Share | -0.31 | 4.91 | 11.02 | 11.46 | 12.98 | 12.80 | 10.99 | 12.53 | 10.81 | 12.41 | 4.50 | -0.40 | -1.51 | 0.43 | 17.16 |
| Total Shareholders' Equity | -34.58M | 316.56M | 713.88M | 746.45M | 829.31M | 814.34M | 695.09M | 682.8M | 707M | 694M | 212M | -17M | -63.8M | 18.3M | 724.7M |
| Common Stock | 676K | 670K | 660K | 654K | 640K | 637K | 633K | 632K | 493K | 517K | 433K | 429K | 426K | 0 | 0 |
| Retained Earnings | -434.54M | -88.91M | 333.59M | 372.59M | 474.42M | 489.34M | 422.93M | 422.37M | 462.57M | 377.02M | 78.98M | 21.84M | -21.48M | 1.42B | 1.2B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -28.96M | -22.97M | -45.67M | -45.92M | -63.8M | -84.47M | -133.63M | -139.23M | -155.7M | -76.15M | -110.08M | -109.62M | -103.44M | -39.7M | -64.67M |
| Minority Interest | 13.7M | 11.37M | 10.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying RYAM stock.
As of 2025, Rayonier Advanced Materials Inc. (RYAM) had total assets of $1.76B including $568.4M in current assets.
Rayonier Advanced Materials Inc. (RYAM) carries total debt of $779.0M, offset by $75.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Rayonier Advanced Materials Inc. (RYAM) has total shareholders' equity (book value) of $316.6M ($4.91 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Rayonier Advanced Materials Inc. (RYAM) reported a current ratio of 1.58x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Negative equity and fixed-cost leverage
Metrics are mathematically derived from official filings.
Equity Erosion Drives Balance Sheet Deterioration
According to reported quarterly figures, RYAM's shareholder equity fell from $755.1M in 2024Q2 to negative $34.6M in 2026Q3, suggesting cumulative losses have now consumed the entire book value base and moved the balance sheet into a vulnerable position.
The move from positive to negative equity is driven primarily by retained earnings flipping from $382.4M to negative $434.5M, which implies accumulated losses have overwhelmed prior capital. Total assets have contracted meaningfully while liabilities have remained near $1.4B, suggesting the deleveraging is coming from asset write-downs rather than debt repayment. Investors should monitor whether further impairments continue to erode the equity base.
Leverage Rises as Equity Base Shrinks
Based on reported figures, total debt has held between roughly $736M and $822M across the period while the debt-to-equity ratio climbed from about 1.0 to well above 2.0 as equity compressed, indicating leverage is rising through equity loss rather than new borrowing.
Because total debt has been broadly flat, the rising leverage ratio appears to be a function of shrinking equity rather than an expansion of obligations. The reported Debt/Equity figure in the most recent quarter is unreliable given that equity is now negative, which warrants caution in interpreting the ratio. The key question is whether debt service can be sustained if operating cash generation remains inconsistent, as the fixed debt load limits financial flexibility.
Asset-Heavy Base Shrinking Through Write-Downs
As reported in financial statements, RYAM's net PP&E declined from roughly $1.1B to $772.2M over recent quarters while goodwill fell from $13.9M to nil, reflecting an asset-heavy mill structure that is being written down rather than expanded.
The business model remains capital-intensive, with PP&E representing the dominant share of total assets, so depreciation and maintenance demands weigh heavily on margins. The disappearance of goodwill points to impairment recognition, which may indicate that acquired value from prior transactions has not been realized. Continued PP&E reduction without clear reinvestment raises questions about the productive capacity of the remaining asset base.
Thin Liquidity Buffer Against Fixed Costs
According to recent SEC filings, RYAM's cash balance fell from $136.1M in 2024Q3 to $61.1M in 2026Q3, while the current ratio moved from 1.73 to 1.28, suggesting a narrowing cushion against operating and debt-service obligations.
A current ratio above 1.0 provides some near-term coverage, but the declining cash balance reduces the margin for absorbing further shocks. Given the high fixed-cost structure and recurring operating losses, the liquidity buffer may be insufficient if working capital reverses. Investors should watch whether cash stabilizes without asset sales or dilutive financing.
Impairments May Mask Underlying Cash Earnings
Based on reported figures, the disappearance of goodwill and the gap between RYAM's large equity losses and its positive operating cash flow suggest non-cash charges may be overstating the deterioration, though this interpretation warrants further investigation.
If the equity decline is driven substantially by impairments rather than recurring cash losses, the headline negative book value could overstate the economic damage to the business. Conversely, repeated write-downs would indicate that the asset base is not earning its carrying value, which is itself a warning sign. Distinguishing between these two readings is essential before drawing firm conclusions about solvency.